Tuesday 14th May 2024 13:00 - 14:00 (BST)
Artificial intelligence offers transformative opportunities for the way health technology assessment (HTA) is conducted. Many of the benefits, such as increased speed and accuracy of data analysis, are easy to envision, however, there are many barriers when it comes to embedding AI into routine HTA practice.
This exciting 60-minute masterclass for LSAA members will look at the opportunities for using AI in HTA and reflect on what can be done to overcome the barriers.
14th May 2024 13:00 – 14:00 (BST)
Speakers
Founder, Talking Medicines
Associate Director (Research), NICE
Founder and CEO, AXIS Consulting
Value & Access Manager, AstraZeneca UK
Head of HTA Consulting UK, AXIS Healthcare Consulting
Professor of Health Technology Assessment, Sheffield University